Press release
Endometrial Cancer Market Insights 2032 Report, Insights by Delveinsight | GlaxoSmithKline Pharmaceuticals, Merck & Co, AstraZeneca, Karyopharm Therapeutics, Evergreen Therapeutics, Incyte Corporation
The market size of Endometrial Cancer is expected to increase during the forecast period with the increasing prevalence, disease awareness, and promising emerging treatment options by leading companies such as GlaxoSmithKline Pharmaceuticals, Merck & Co, AstraZeneca, Karyopharm Therapeutics, Evergreen Therapeutics, Incyte Corporation, and many others[Nevada, United States] - DelveInsight's "Endometrial Cancer Market Insights, Epidemiology, and Market Forecast 2032." offers a detailed examination of Endometrial Cancer, covering historical and predicted epidemiology, market trends, and treatment scenarios in the United States, EU4 (Germany, Spain, Italy, France), the United Kingdom, and Japan.
To Know in detail about the Endometrial Cancer Market outlook, drug uptake, treatment scenario and epidemiology trends, Click here: https://www.delveinsight.com/report-store/endometrial-cancer-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rkpr
Key Findings from the Endometrial Cancer Market Report:
The Endometrial Cancer market size is poised for significant growth, with an anticipated Compound Annual Growth Rate (CAGR) during the study period (2019-2032).
In August, 2024: Merck Sharp & Dohme LLC announced that the company is looking for new ways to treat people with endometrial cancer (EC) who have previously received treatment with platinum based therapy (a type of chemotherapy) and immunotherapy.
In August, 2024: Hoffmann-La Roche announced that a Phase II, global, single-arm study is designed to evaluate the efficacy, safety, and pharmacokinetics of giredestrant monotherapy in participants with Grade 1 endometrioid endometrial cancer.
In August, 2024: Merck Sharp & Dohme LLC announced that the purpose of their study is to determine the safety and efficacy of belzutifan in combination with pembrolizumab and lenvatinib in multiple solid tumors including hepatocellular carcinoma (HCC), colorectal cancer (CRC), pancreatic ductal adenocarcinoma (PDAC), biliary tract cancer (BTC), endometrial cancer (EC),and esophageal squamous cell carcinoma (ESCC).
In July, 2024: Sichuan Baili Pharmaceutical Co., Ltd. announced a Phase Ib/II clinical study to evaluate the safety, tolerability, pharmacokinetics and efficacy of BL-B01D1 for injection in patients with multiple solid tumors, including recurrent or metastatic gynecological malignancies
According to the National Cancer Institute, approximately 3 in 100 women will be diagnosed with uterine cancer at some point in their lives. More than 80 percent of people with uterine cancer survive for five years or longer after receiving the diagnosis. Endometrial cancer comprises about 4% of all cancers in women globally.
According to a study conducted by Guzzinati Stefano et al. (2018), around 103,321 Italian women i.e. 7.2% of the 1,443,942 Italian women diagnosed with cancer were affected by endometrial
According to Palacios et al. (2022), in 2018, in Spain And France, the incidence rates were 13.7 and 14.7cases/100,000 person-years.
Key Endometrial Cancer Companies are as follows:GlaxoSmithKline Pharmaceuticals, Merck & Co, AstraZeneca, Karyopharm Therapeutics, Evergreen Therapeutics, Incyte Corporation, and many others
Key Endometrial Cancer Therapies are as follow: retifanlimab, epacadostat, pemigatinib, Doxorubicin, Paclitaxel, Giredestrant, HS-20089
Launching multiple stage Endometrial Cancer pipeline products is expected to revolutionize market dynamics, further propelling market growth.
Dive into our detailed Hypophosphatasia market research report to uncover actionable insights, industry forecasts, and competitive analysis @ https://www.delveinsight.com/sample-request/endometrial-cancer-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rkpr
Endometrial Cancer Market Overview:
The DelveInsight's Endometrial Cancer market report gives a thorough understanding of Endometrial Cancer symptoms, risks, causes, pathophysiology, diagnosis, and treatment. Endometrial cancer develops when cells in the endometrium (the inner lining of the uterus) begin to grow out of control. Cancerous cells can arise in almost any portion of the body and spread to other parts. Endometrial cancer is sometimes called uterine cancer. It is often detected at an early stage because it frequently produces abnormal vaginal bleeding.
Endometrial Cancer Drugs Uptake and Pipeline Development Activities:
The section on drug uptake examines how quickly new or upcoming potential drugs are being adopted during the study period. This report details market uptake by individual drugs, patient adoption of different therapies, and the sales performance of each drug. It also offers insights into the development activities in the Endometrial Cancer Pipeline, evaluating therapeutic candidates at various stages and highlighting the key companies involved
For more information about Endometrial Cancer companies working in the treatment market, visit: https://www.delveinsight.com/sample-request/endometrial-cancer-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rkpr
Endometrial Cancer Therapies and Key Companies:
Retifanlimab: Incyte Corporation,
Paclitaxel: Merck Sharp & Dohme LLC
Giredestrant: Hoffmann-La Roche
HS-20089: Hansoh BioMedical R&D Company
Endometrial Cancer Epidemiology:
The epidemiology section offers insights into historical, current, and projected trends in the seven major markets (7MM) from 2019 to 2032. It examines various studies and perspectives to identify the factors driving current and anticipated trends. The segmentation covers total prevalence, prevalence based on severity, gender-specific prevalence, and diagnosed cases of both episodic and chronic Endometrial Cancer.
Seize Market Opportunities with Our Expert Analysis! Our report delivers valuable insights into market dynamics, key players, and emerging trends @ https://www.delveinsight.com/sample-request/endometrial-cancer-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rkpr
Endometrial Cancer Epidemiology Segmentation:
The Endometrial Cancer market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
Total Prevalence of Endometrial Cancer
Prevalent Cases of Endometrial Cancer by severity
Gender-specific Prevalence of Endometrial Cancer
Diagnosed Cases of Episodic and Chronic Endometrial Cancer
Endometrial Cancer Market Drivers:
Rising incidence rates in endometrial cancer
Increasing awareness among individuals
Improved healthcare infrastructure
Stay Ahead in a Competitive Landscape with Our Exhaustive Market Research Report-Dive Into Detailed Analysis, Key Trends, and Future Projections @ https://www.delveinsight.com/sample-request/endometrial-cancer-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rkpr
Scope of the Endometrial Cancer Market Report:
Study Period: 2019-2032
Coverage: 7MM (The United States, EU5, and Japan)
Key Endometrial Cancer Companies: GlaxoSmithKline Pharmaceuticals, Merck & Co, AstraZeneca, Karyopharm Therapeutics, Evergreen Therapeutics, Incyte Corporation
Key Endometrial Cancer Therapies: retifanlimab, epacadostat, pemigatinib, Doxorubicin, Paclitaxel, Giredestrant, HS-20089
Endometrial Cancer Therapeutic Assessment: Current marketed and emerging therapies
Endometrial Cancer Market Dynamics: Endometrial Cancer Market drivers and Endometrial Cancer barriers
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
Endometrial Cancer Unmet Needs: Insights into unmet needs, KOL's views, Analyst's views, Market Access, and Reimbursement.
To access the full report and gain a deeper understanding of Endometrial Cancer market outlook, drug uptake, treatment scenario, and epidemiology trends: https://www.delveinsight.com/sample-request/endometrial-cancer-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rkpr
Table of Content:
1. Key Insights
2. Executive Summary of Endometrial Cancer
3. Endometrial Cancer Market Overview at a Glance
4. Disease Background and Overview
5. Current Treatment and Practise Guidelines
6. Epidemiology and Patient Population
7. Country-wise Epidemiology of Endometrial Cancer
8. Patient Journey
9. Marketed Therapies
To be Continued in the final report…
10. Combinational Therapies: Marketed
11. Emerging Therapies
12. Emerging Combinational Therapies
13. Other Promising Therapies
14. Endometrial Cancer: Seven Major Market Analysis
15. Market Outlook
16. Unmet Needs
17. KOL Views
18. SWOT Analysis
19. Market Access and Reimbursement
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight
List of Top Selling Market Research Reports in 2024
Surgical Energy Generators Market- https://www.delveinsight.com/report-store/surgical-energy-generators-market
Surgical Sealant Tissue Patch Market- https://www.delveinsight.com/report-store/surgical-sealant-tissue-patch-market
Surgical Stapling Devices Market- https://www.delveinsight.com/report-store/surgical-stapling-devices-market
Vital Sign Monitoring Devices Market- https://www.delveinsight.com/report-store/vital-sign-monitors-external-remote-patient-monitoring-devices-market
Syphilis Market- https://www.delveinsight.com/report-store/syphilis-market
Vitreoretinal Surgery Devices Market- https://www.delveinsight.com/report-store/vitreoretinal-surgery-devices-market
Pelvic Organ Prolapse Market- https://www.delveinsight.com/report-store/pelvic-organ-prolapse-market
Scoliosis Market- https://www.delveinsight.com/report-store/scoliosis-market
SGLT2 Inhibitors Market- https://www.delveinsight.com/report-store/sglt2-inhibitors-market
Urinary Catheters Market- https://www.delveinsight.com/report-store/urinary-catheters-market
Carcinoid Syndrome Market- https://www.delveinsight.com/report-store/carcinoid-syndrome-market
Cardiac Monitoring Devices Market- https://www.delveinsight.com/report-store/cardiac-monitoring-devices-market
Varicose Vein Treatment Devices Market- https://www.delveinsight.com/report-store/varicose-vein-treatment-devices-market
Bone Growth Stimulators Market- https://www.delveinsight.com/report-store/bone-growth-stimulators-market
Skin Neoplasms Market- https://www.delveinsight.com/report-store/skin-neoplasms-market
Thrombectomy Devices Market- https://www.delveinsight.com/report-store/thrombectomy-devices-market
Novel Drug Delivery Devices Market- https://www.delveinsight.com/report-store/novel-drug-delivery-devices
Lymphedema Market- https://www.delveinsight.com/report-store/lymphedema-market
Artificial Disc Market- https://www.delveinsight.com/report-store/artificial-disc-market
Exocrine Pancreatic Insufficiency Market- https://www.delveinsight.com/report-store/exocrine-pancreatic-insufficiency-epi-market
Fabry Disease Market- https://www.delveinsight.com/report-store/fabry-disease-market
Overactive Bladder Market- https://www.delveinsight.com/report-store/overactive-bladder-oab-market
Total Knee Arthroplasty Market- https://www.delveinsight.com/report-store/total-knee-arthroplasty-market
Hip Replacement Devices Market- https://www.delveinsight.com/report-store/hip-reconstruction-devices-market
Lactose Intolerance Market- https://www.delveinsight.com/report-store/lactose-intolerance-market
HDAC Inhibitors Market- https://www.delveinsight.com/report-store/hdac-inhibitors-market
Ventral Hernia Market- https://www.delveinsight.com/report-store/ventral-hernia-market
Facial Lines Market- https://www.delveinsight.com/report-store/facial-lines-market
Medical Marijuana Market- https://www.delveinsight.com/report-store/medical-marijuana-market-insight
Microscopy Device Market- https://www.delveinsight.com/report-store/microscopy-device-market
About DelveInsight:
DelveInsight is a leading market research firm providing insightful solutions and services to pharmaceutical and life sciences companies. With a commitment to delivering accurate and comprehensive reports, DelveInsight empowers businesses to make informed decisions and navigate the complexities of the healthcare industry
Company Name: DelveInsight Business Research LLP
Contact Person: Ram Kapoor
Email: info@delveinsight.com
Contact No.: +91-9650213330
City: 304 S. Jones Blvd #2432, Las Vegas
State: Nevada (89107)
Country: United States
Website: https://www.delveinsight.com/consulting
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Endometrial Cancer Market Insights 2032 Report, Insights by Delveinsight | GlaxoSmithKline Pharmaceuticals, Merck & Co, AstraZeneca, Karyopharm Therapeutics, Evergreen Therapeutics, Incyte Corporation here
News-ID: 3651543 • Views: …
More Releases from DelveInsight Business Research LLP

Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight and stay ahead…

Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore…

Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight…

Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market…
More Releases for Endometrial
Rising Prevalence Of Endometrial Cancer Through Advances In The Endometrial Canc …
The Endometrial Cancer Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Endometrial Cancer Treatment Market Size and Projected Growth Rate?
The Endometrial Cancer Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to…
Advanced Endometrial Cancer Pipeline: A Spotlight on the Most Promising Developm …
The Advanced Endometrial Cancer Pipeline Insight 2023 report by DelveInsight offers a thorough global overview of Advanced Endometrial Cancer treatments, including those already in the market, as well as those in different phases of clinical development. Prominent pharmaceutical firms are dedicated to progressing the Advanced Endometrial Cancer pipeline landscape and fostering the potential growth of Advanced Endometrial Cancer therapeutic advancements.
Key Takeaways from the Advanced Endometrial Cancer Pipeline Report
• DelveInsight's Advanced…
Endometrial Biopsy Cannulae Market 2023
The report presents detailed information regarding the prominent players and potential competitors in the Endometrial Biopsy Cannulae market. It includes comprehensive insights into their worldwide presence, economic performance, strategies, upcoming product releases, research and development initiatives, and a SWOT analysis. Additionally, the report analyses revenue share and contact details for each player.
This comprehensive report aims to evaluate and forecast the market size for Fuel Monitoring Systems. It analyses revenue, growth…
Hysteroscopic Endometrial Resection Market - Transforming Hysteroscopy, Enhancin …
Newark, New Castle, USA - Growth Plus Reports has published a new report on Hysteroscopic Endometrial Resection Market, which includes a detailed analysis based on competitors and important market segments (2023-2031). The Global Hysteroscopic Endometrial Resection provides a thorough analysis of many segments such as opportunities, market size, developments, innovation, sales, and overall growth of leading players. The research is based on primary and secondary statistical data, and it includes…
Endometrial Ablation Market snapshot 2024
Global Endometrial Ablation Market: Snapshot
With the rising prevalence of gynecology disorders, such as polycystic ovarian disease (PCOD), abnormal vaginal bleeding, the global adoption of endometrial ablation procedures has increased significantly, leading to an impressive rise in the worldwide endometrial ablation market. Apart from this, the upswing in the incidence rate of cervical and endometrial cancer in women is also driving the growth of this market substantially across the world.
Download The…
Global Endometrial Ablation Market: Radiofrequency Endometrial Ablation Devices …
With the presence of large players, such as Hologic Corp., Boston Scientific Corp., Cooper Surgical Inc., Ethicon Inc., and Medtronic Plc at the global level, the worldwide market for endometrial ablation demonstrates a highly competitive landscape, finds a new research report by Transparency Market Research (TMR).
The market players are focusing aggressively on developing their offerings technologically, which is likely to lead to price differentiation, resulting in intense rivalry between these…